#ascoadvocacyday : a great day advocating for research funding, reducing chemo drug shortages, & permanent telehealth reimbursement!!

Even more enthusiastic about joining Yale Internal Medicine Yale Traditional Medicine Residency Program after listening to the 'State of the Cancer Center' by Eric Winer, MD

So many giants to learn from with a a wonderful culture and vision! David Braun

I am absolutely thrilled to be joining the editorial team at JCO Clinical Cancer Informatics for a 5-year term as an Associate Editor. I cannot think of a better team to work with!
SanjayAnejaMD Madhu Behera, PhD Russell Rockne Umit Topaloglu Aakash Desai, MD, MPH

Consider sending us your clinical informatics papers!

Congratulations to CVRC’s Dr. Emily Lau, one of the select Massachusetts Life Sciences Center Women’s Health Awardees. Part of $2.6 million in awards and announced by Maura Healey Maura Healey, Dr. Lau’s research was recognized for its potential to improve women’s health outcomes.

TIME's list of the 100 Most Influential People in the world is out. I'm honored, delighted, and grateful to be a part of this incredible group #TIME100 🙏🏼🙏🏼🙏🏼 TIME
time.com/6964230/akiko-…

Such a great honor to be highlighted by Journal for ImmunoTherapy of Cancer for work with Amin Nassar, MD Guru P. Sonpavde, MD Dana-Farber and many friends and collaborators. A great platform advocating for trainees always!

Phase III ALINA trial of adjuvant alectinib for resected stage Ib-IIIA (AJCC v7) #ALK NSCLC now NEJM. Compared 2y of alectinib to chemotherapy. Alectinib improved DFS (HR 0.24) with 2y DFS rate 94% vs 63%! CNS DFS 0.22, OS pending. Standard of care IMO.

nejm.org/doi/full/10.10…

We are proud to support our friend and Yale Cancer Center Smilow Cancer Hospital colleague, Pat LoRusso, newly inducted AACR President Patricia M. LoRusso, during her upcoming year as President of @AACR #AACR2024 . We know Pat will accomplish great things and we are already looking forward to #AACR2025 !

Yesterday AACR business meeting #AACR24 Dr. Patricia LoRusso Yale Cancer Center Smilow Cancer Hospital was introduced as the 2024-25 AACR President. She outlined an innovative vision for the coming year! AACRPres

Truly an honor to receive this designation alongside extraordinary colleagues and mentors. Thank you #ASCO . #FASCO UC San Diego Health Moores Cancer Center

Congrats to Dana-Farber’s Nolan Priedigkeit, MD, PhD, (@npriedig), recipient of #AACR24 -Conquer Cancer, the ASCO Foundation Young Investigator Award for Translational Cancer Research. His project will assess fusion RNA targets in advanced breast cancers.

ms.spr.ly/6016cFT3g

Looking forward to talking about ancestry-specific biases in tumor mutational burden with Alanna Church, MD in a few weeks! Related to our prior work here: pubmed.ncbi.nlm.nih.gov/36179682/

Couldn’t be more happy to see this project led by the one and only Amin Nassar to be selected for Rapid Oral ASCO24 - Rafeh Naqash, MD
Amin Nassar, MD ASCO Yale School of Medicine

#ASCO24 #Cancer #OncoDaily #Oncology #OUHealth #YaleSchoolOfMedicine

oncodaily.com/43803.html

Press release: phase III ADRIATIC study of durvalumab after chemoradiation for limited stage #SCLC improves both PFS and OS. Follows the PACIFIC approach, randomizing after definitive chemoradiation. Await data on durva + tremelimumab arm. #LCSM

astrazeneca.com/media-centre/p…

#Together we are the elements of change and innovations to generate the #NextGen studies! very productive discussions with Razelle Kurzrock, MD Young Kwang Chae, MD, MPH, MBA Vineeth Sukrithan Krishna Soujanya Gunturu MD Parminder singh Dr. Nagla Abdel Karim SWOG Cancer Research Network Chair Elect Dawn Hershman The Hope Foundation for Cancer Research

Enjoyed putting this piece led by ⁦⁦Zahraa Rahal⁩ . We need to make sense of mechanisms that shape the fate of mutant cells in “normal” tissues, e.g., tissue injury, inflammation, etc. 🙏Elizabeth McKenna Cancer Discovery for letting us share our thoughts! aacrjournals.org/cancerdiscover…

What a stellar presentation by Rafeh Naqash, MD (as usual!!). Congrats!!

1/ Thrilled to share that our paper “Impact of RCC molecular subtypes on immunotherapy & targeted therapy outcomes” is now published in Cancer Cell
Collaborative effort co-led w/ Chris Labaki & Tejas Jammihal under Eli Van Allen Sachet Ashok Shukla Toni Choueiri, MD David Braun ‘s mentorship

Hopefully everyone makes it to SWOG Cancer Research Network #Seattle safely !
Tune into our Plenary session tomorrow 3.30 pm Pacific and get a glimpse of some omics research in rare tumors The Hope Foundation for Cancer Research Elad Sharon Amin Nassar, MD Hassan Abushukair Ayah Al-Bzour OU Health Stephenson Cancer Center Sumanta K. Pal, MD, FASCO Caris Life Sciences Tempus

So happy for Rafeh Naqash, MD who goes above and beyond in helping others (mentees, patients, colleagues)! Not to miss